Literature DB >> 28171686

The relationship between procalcitonin and thyroid autoantibodies in patients with autoimmune thyroiditis.

Ali Oncul1, Ihsan Ates1, Mehmet Fettah Arikan1, Nisbet Yilmaz1, Canan Topcuoglu2, Fatma Meric Yilmaz2, Mustafa Altay1.   

Abstract

BACKGROUND: The aim of this study is to investigate the serum levels of procalcitonin and its association with autoantibodies in patients with euthyroid Hashimoto's thyroiditis.
METHODS: A total of 80 participants were included in the study; 40 of which were newly diagnosed with Hashimoto's thyroiditis, aged over 18, and 40 of which were healthy volunteers. The serum levels of procalcitonin were measured by enzyme-linked immunosorbent assay kit. Thyroid function tests were analyzed in hormone laboratory with Electro-chemiluminescence immunoassay.
RESULTS: Hashimoto's thyroiditis patients had higher median procalcitonin levels than those of the control group (34.3 pg/mL vs 27.8 pg/mL respectively; P=.037). Also, male patients had higher median procalcitonin levels as compared to female patients (37 pg/mL vs 27 pg/mL respectively; P=.013). In the Hashimoto's thyroiditis group, procalcitonin level was positively correlated with anti-thyroglobulin and anti-thyroid peroxidase levels (r=.559, P<.001; r=634, P<.001, respectively). The procalcitonin and anti-thyroid peroxidase levels were identified to be an independent predictor in diagnosis of Hashimoto's thyroiditis.
CONCLUSIONS: The fact that procalcitonin was found to be correlated with thyroid autoantibodies and found to be an independent risk factor for Hashimoto's thyroiditis in the regression analysis in the framework of this study urges us to think that procalcitonin may be associated with the autoimmunity.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  autoimmunity; calcitonin; chronic lymphocytic thyroiditis; pre-procalcitonin

Mesh:

Substances:

Year:  2017        PMID: 28171686      PMCID: PMC6817117          DOI: 10.1002/jcla.22123

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  28 in total

1.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

2.  Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener's granulomacytosis.

Authors:  K Zycinska; K A Wardyn; T M Zielonka; P Tyszko; M Straburzynski
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

3.  Calcitonin biosynthesis: evidence for a precursor.

Authors:  F Moya; A Nieto; J L R-Candela
Journal:  Eur J Biochem       Date:  1975-07-01

Review 4.  Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

Authors:  Bernard Uzzan; Régis Cohen; Patrick Nicolas; Michel Cucherat; Gérard-Yves Perret
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

Review 5.  Serum procalcitonin in systemic autoimmune diseases--where are we now?

Authors:  Irina Buhaescu; Robert A Yood; Hassan Izzedine
Journal:  Semin Arthritis Rheum       Date:  2010-02-04       Impact factor: 5.532

6.  The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto's thyroiditis.

Authors:  Ihsan Ates; Mustafa Altay; Fatma Meric Yilmaz; Canan Topcuoglu; Nisbet Yilmaz; Dilek Berker; Serdar Guler
Journal:  Eur J Endocrinol       Date:  2016-03-07       Impact factor: 6.664

7.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

8.  Acute-phase reactans in Hashimoto thyroiditis.

Authors:  Sacide Erden; Suna Buyukozturk; Pervin Vural; Sevgin Değirmencioğlu
Journal:  Int Immunopharmacol       Date:  2008-10-07       Impact factor: 4.932

9.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  1 in total

1.  Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease.

Authors:  Vania Cuna; Viola Menghi; Giorgia Comai; Maria Cappuccilli; Giuseppe Cianciolo; Concettina Raimondi; Francesco Grammatico; Gabriele Donati; Olga Baraldi; Irene Capelli; Gaetano LA Manna
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.